Emily Peach

424 total citations
17 papers, 241 citations indexed

About

Emily Peach is a scholar working on Nephrology, Epidemiology and Immunology. According to data from OpenAlex, Emily Peach has authored 17 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 5 papers in Epidemiology and 3 papers in Immunology. Recurrent topics in Emily Peach's work include Chronic Kidney Disease and Diabetes (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Dialysis and Renal Disease Management (3 papers). Emily Peach is often cited by papers focused on Chronic Kidney Disease and Diabetes (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Dialysis and Renal Disease Management (3 papers). Emily Peach collaborates with scholars based in United Kingdom, United States and Canada. Emily Peach's co-authors include Navdeep Tangri, Salvatore Barone, Pamela Kushner, Matthew Arnold, Markus P. Schneider, Krister Järbrink, Stefan Franzén, Hungta Chen, Fiona Pearce and Richard Hubbard and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Epidemiology and Journal of the American Society of Nephrology.

In The Last Decade

Emily Peach

17 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Peach United Kingdom 9 84 44 39 37 35 17 241
Slobodan Peric Austria 9 33 0.4× 42 1.0× 80 2.1× 43 1.2× 55 1.6× 13 329
Mürvet Yılmaz Türkiye 12 110 1.3× 21 0.5× 17 0.4× 43 1.2× 38 1.1× 33 286
Kate Wiles United Kingdom 13 83 1.0× 51 1.2× 38 1.0× 24 0.6× 31 0.9× 38 677
Elaine Lam Canada 7 79 0.9× 44 1.0× 24 0.6× 31 0.8× 29 0.8× 7 433
Paula Maier United States 7 300 3.6× 73 1.7× 13 0.3× 34 0.9× 35 1.0× 9 535
Yael Einbinder Israel 11 59 0.7× 9 0.2× 34 0.9× 36 1.0× 18 0.5× 29 234
Lien‐Cheng Hsiao Taiwan 6 59 0.7× 24 0.5× 10 0.3× 47 1.3× 19 0.5× 9 186
Qiangsheng He China 12 47 0.6× 59 1.3× 26 0.7× 78 2.1× 16 0.5× 39 416
Juliette C. Thompson United Kingdom 11 17 0.2× 66 1.5× 78 2.0× 41 1.1× 41 1.2× 18 344
Chia-shi Wang United States 10 162 1.9× 56 1.3× 16 0.4× 13 0.4× 13 0.4× 18 262

Countries citing papers authored by Emily Peach

Since Specialization
Citations

This map shows the geographic impact of Emily Peach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Peach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Peach more than expected).

Fields of papers citing papers by Emily Peach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Peach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Peach. The network helps show where Emily Peach may publish in the future.

Co-authorship network of co-authors of Emily Peach

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Peach. A scholar is included among the top collaborators of Emily Peach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Peach. Emily Peach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tangri, Navdeep, Markus P. Schneider, Luca De Nicola, et al.. (2023). Prevalence of undiagnosed stage 3 chronic kidney disease in France, Germany, Italy, Japan and the USA: results from the multinational observational REVEAL-CKD study. BMJ Open. 13(5). e067386–e067386. 66 indexed citations
2.
Tangri, Navdeep, Emily Peach, Stefan Franzén, Salvatore Barone, & Pamela Kushner. (2023). Patient Management and Clinical Outcomes Associated with a Recorded Diagnosis of Stage 3 Chronic Kidney Disease: The REVEAL-CKD Study. Advances in Therapy. 40(6). 2869–2885. 33 indexed citations
3.
Rutter, Megan, Emily Peach, Peter Lanyon, et al.. (2023). The incidence of Kawasaki disease using hospital admissions data for England 2006–2021. Lara D. Veeken. 62(9). 3117–3125. 8 indexed citations
4.
Schneider, Markus P., et al.. (2022). UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN PATIENTS WITH A HISTORY OF HEART FAILURE: A REPORT FROM REVEAL-CKD. Journal of the American College of Cardiology. 79(9). 440–440. 2 indexed citations
5.
Tangri, Navdeep, et al.. (2022). REVEAL CKD: Estimated Glomerular Filtration Rate (eGFR) Decline Before and After a CKD Diagnosis Among Patients With CKD Stage 3. Journal of the American Society of Nephrology. 33(11S). 302–302. 1 indexed citations
6.
Schneider, Markus P., et al.. (2022). POS-213 REVEAL-CKD: PREVALENCE OF UNDIAGNOSED EARLY CHRONIC KIDNEY DISEASE IN GERMANY. Kidney International Reports. 7(2). S93–S93. 5 indexed citations
7.
Hannah, Jennifer, Patrick Gordon, James Galloway, et al.. (2022). Validation of methods to identify people with idiopathic inflammatory myopathies using hospital episode statistics. Rheumatology Advances in Practice. 6(3). rkac102–rkac102. 8 indexed citations
8.
Tangri, Navdeep, Markus P. Schneider, Luca De Nicola, et al.. (2022). REVEAL-CKD: Management and Monitoring of Patients With CKD Stage 3 in France, Germany, Italy, Japan, and the United States. Journal of the American Society of Nephrology. 33(11S). 302–303. 2 indexed citations
9.
Nicola, Luca De, et al.. (2022). MO509: Reveal-CKD: Prevalence of Undiagnosed Stage 3 Chronic Kidney Disease Italy. Nephrology Dialysis Transplantation. 37(Supplement_3). 2 indexed citations
10.
Rutter, Megan, Peter Lanyon, Matthew J. Grainge, et al.. (2021). COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project. Lara D. Veeken. 61(8). 3161–3171. 12 indexed citations
11.
Khakwani, Aamir, Emily Peach, Richard Hubbard, et al.. (2021). Biomarker Testing for People With Advanced Lung Cancer in England. JTO Clinical and Research Reports. 2(6). 100176–100176. 18 indexed citations
12.
Peach, Emily, Fiona Pearce, Jack Gibson, et al.. (2021). Opioids and the Risk of Fracture: A Self-Controlled Case Series Study in the Clinical Practice Research Datalink. American Journal of Epidemiology. 5 indexed citations
13.
Kushner, Pamela, Emily Peach, Eric Wittbrodt, et al.. (2021). Investigating the global prevalence and consequences of undiagnosed stage 3 chronic kidney disease: methods and rationale for the REVEAL-CKD study. Clinical Kidney Journal. 15(4). 738–746. 16 indexed citations
14.
Hannah, Jennifer, Patrick Gordon, James Galloway, et al.. (2021). P090 Validation of hospital episode statistics data to enable national registration of idiopathic inflammatory myopathies. Lara D. Veeken. 60(Supplement_1). 1 indexed citations
15.
Peach, Emily, Megan Rutter, Peter Lanyon, et al.. (2020). Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic. Lara D. Veeken. 60(4). 1902–1909. 34 indexed citations
16.
Brooks, Alenka J, Paul Norman, Emily Peach, et al.. (2019). Prospective Study of Psychological Morbidity and Illness Perceptions in Young People With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 13(8). 1003–1011. 26 indexed citations
17.
Peach, Emily & Jilly Martin. (2016). Utilising implementation intentions to promote healthy eating in adolescents. Health Psychology and Behavioral Medicine. 5(1). 1–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Slobodan Peric Breakdown of academic impact, for papers by Mürvet Yılmaz Breakdown of academic impact, for papers by Kate Wiles Breakdown of academic impact, for papers by Elaine Lam Breakdown of academic impact, for papers by Paula Maier Breakdown of academic impact, for papers by Yael Einbinder Breakdown of academic impact, for papers by Lien‐Cheng Hsiao Breakdown of academic impact, for papers by Qiangsheng He Breakdown of academic impact, for papers by Juliette C. Thompson Breakdown of academic impact, for papers by Chia-shi Wang
Rankless by CCL
2026